Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Meprobamate MeSH Descriptor Data 2025


MeSH Heading
Meprobamate
Tree Number(s)
D02.241.081.251.510
Unique ID
D008620
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D008620
Scope Note
A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)
Entry Term(s)
Dapaz
Equanil
Meprospan
Miltown
Méprobamate Richard
Tranmep
Visano
Pharm Action
Anticonvulsants
Hypnotics and Sedatives
Muscle Relaxants, Central
Anti-Anxiety Agents
Registry Numbers
9I7LNY769Q
0
Related Numbers
57-53-4
CAS Type 1 Name
1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate
NLM Classification #
QV 77.9
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2016/07/01
Meprobamate Preferred
Equanil Narrower
Miltown Narrower
Dapaz Narrower
Meprospan Narrower
Tranmep Narrower
Visano Narrower
Méprobamate Richard Narrower
page delivered in 0.135s